Clinical Trials on Disturbance of Visuo-spatial Working Memory in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Sudimplant SAS - Groupe TBR
- Korea Otsuka International Asia Arab
- Gunkang Pharmaceuticals, Inc
- Foshan Sanshui District People's Hospital
- S-Biotek Holding ApS
- United States Department of Defense (DOD)
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Julian Taylor Green
- University of Applied Sciences Jena
- Paulo Sérgio Gomes Nogueira Borges
- Lilly PharmaceuticalCompany
- Arsha Vidya Tirtha
- Eurotrials Brasil Consultores Cientificos Ltda
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Rivierduinen, Centre for Personality disorders Jelgersma
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Oblikue Consulting
- Iyad Naeem Muhammad, PhD
- Plethora Solutions Ltd
- Cardiovascular Center Dedinje, Belgrade, Serbia
- View Full List
Medical Conditions
- Visual Attention Span Deficit
- Immunologically-induced Lung Disease
- Puberty, Delayed
- Chemotherapy-Induced Neutropenia
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Thyroid and Parathyroid Surgery
- Advance Directive Completion
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Deformity Flexion
- Anemia Acute
- Serum Albumin Low
- Vibration; Exposure
- Hypothermia Following Anesthesia, Sequela
- Malaria,Falciparum
- Testicular Teratoma
- Brain Tumor, Primary
- Huntington Chorea
- Gray Platelet Syndrome
- Blepharospasm of Both Eyelids
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- View Full List
Drug Interventions
- Mineralocorticoid receptor antagonist
- Oxycodone
- Pegfilgrastim
- Vosaroxin
- ABY-035 i.v.
- Cyanoacrylate
- Bimatoprost 0.03% eye drops
- Acalabrutinib in combination with VR
- Sorafenib
- MMV390048 120mg
- Furmonertinib 160 mg
- Cytisine
- Pemetrexed
- Rovalpituzumab tesirine
- S-Adenosyl-Methionine
- Celecoxib
- F520
- Ebselen
- Standard medical therapy
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belgium
- Contract Research Organizations in Burundi
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Poland
- Contract Research Organizations in Portugal
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Uruguay
- CRO list by country